These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 17682981

  • 1. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
    Hung CC, Hung MN, Hsueh PR, Chang SY, Chen MY, Hsieh SM, Sheng WH, Sun HY, Huang YT, Lo YC, Hsiao CF, Chang SC.
    Clin Infect Dis; 2007 Sep 01; 45(5):e60-7. PubMed ID: 17682981
    [Abstract] [Full Text] [Related]

  • 2. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I, Pallares R, Tubau F, Schulze MH, Llopis F, Podzamczer D, Liñares J, Gudiol F, Spanish Pneumococcal Infection Study Network (G03/103).
    Arch Intern Med; 2005 Jul 11; 165(13):1533-40. PubMed ID: 16009870
    [Abstract] [Full Text] [Related]

  • 3. Risk of recurrent nontyphoid Salmonella bacteremia in human immunodeficiency virus-infected patients with short-term secondary prophylaxis in the era of combination antiretroviral therapy.
    Chou YJ, Lin HW, Yang CJ, Chen MY, Sheng WH, Liu WC, Chang SY, Hung CC, Hsueh PR, Chang SC.
    J Microbiol Immunol Infect; 2016 Oct 11; 49(5):760-767. PubMed ID: 26316009
    [Abstract] [Full Text] [Related]

  • 4. Lack of fluoroquinolone resistance in non-typhoidal salmonella bacteremia in HIV-infected patients in an urban US setting.
    Forrest GN, Wagner LA, Talwani R, Gilliam BL.
    J Int Assoc Physicians AIDS Care (Chic); 2009 Oct 11; 8(6):338-41. PubMed ID: 19952286
    [Abstract] [Full Text] [Related]

  • 5. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG, Soe MM, Nesheim SR, Sullivan KM, Abrams E, Farley J, Palumbo P, Koenig LJ, Bulterys M.
    Pediatrics; 2008 May 11; 121(5):e1229-39. PubMed ID: 18450865
    [Abstract] [Full Text] [Related]

  • 6. Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan.
    Hung CC, Hsiao CF, Chen MY, Hsieh SM, Chang SY, Sheng WH, Sun HY, Chang SC.
    Jpn J Infect Dis; 2006 Aug 11; 59(4):222-8. PubMed ID: 16936339
    [Abstract] [Full Text] [Related]

  • 7. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, Wöhrmann A, Fätkenheuer G.
    Infection; 2005 Oct 11; 33(5-6):345-9. PubMed ID: 16258865
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan.
    Lin CY, Chen MY, Hsieh SM, Sheng WH, Sun HY, Lo YC, Hung CC, Chang SC.
    J Microbiol Immunol Infect; 2009 Jun 11; 42(3):227-33. PubMed ID: 19812856
    [Abstract] [Full Text] [Related]

  • 10. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
    Katsarou O, Touloumi G, Antoniou A, Kouramba A, Hatzakis A, Karafoulidou A.
    Haemophilia; 2005 Jul 11; 11(4):360-5. PubMed ID: 16011588
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
    Mesarić B, Lisić M, Kniewald T, Ugrinović N, Begovac J.
    Lijec Vjesn; 2005 Jul 11; 127(5-6):123-8. PubMed ID: 16281473
    [Abstract] [Full Text] [Related]

  • 14. Changing sociodemographic and clinical characteristics of tuberculosis among HIV-infected patients, New York City, 1992-2005.
    Harris TG, Li J, Hanna DB, Munsiff SS.
    Clin Infect Dis; 2010 Jun 01; 50(11):1524-31. PubMed ID: 20415570
    [Abstract] [Full Text] [Related]

  • 15. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I, Quereda C, Moreno A, Pérez-Elías MJ, Dronda F, Casado JL, Muriel A, Masjuán J, Alonso-de-Leciñana M, Moreno S.
    Cerebrovasc Dis; 2009 Jun 01; 27(6):559-63. PubMed ID: 19390181
    [Abstract] [Full Text] [Related]

  • 16. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L.
    J Infect Dis; 2009 Nov 15; 200(10):1490-7. PubMed ID: 19832114
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi.
    Gordon MA, Graham SM, Walsh AL, Wilson L, Phiri A, Molyneux E, Zijlstra EE, Heyderman RS, Hart CA, Molyneux ME.
    Clin Infect Dis; 2008 Apr 01; 46(7):963-9. PubMed ID: 18444810
    [Abstract] [Full Text] [Related]

  • 19. Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection.
    Butt AA, Fultz SL, Kwoh CK, Kelley D, Skanderson M, Justice AC.
    Hepatology; 2004 Jul 01; 40(1):115-9. PubMed ID: 15239093
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.